Suppr超能文献

甲型流感病毒/香港/123/77(H1N1)ts-1A2及冷适应重组病毒在血清阴性成年志愿者中的评估。

Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers.

作者信息

Murphy B R, Rennels M B, Douglas R G, Betts R F, Couch R B, Cate T R, Chanock R M, Kendal A P, Maassab H F, Suwanagool S, Sotman S B, Cisneros L A, Anthony W C, Nalin D R, Levine M M

出版信息

Infect Immun. 1980 Aug;29(2):348-55. doi: 10.1128/iai.29.2.348-355.1980.

Abstract

Two attenuated influenza A donor viruses, the A/Udorn/72 ts-1A2 and the A/Ann Arbor/6/60 cold-adapted (ca) viruses, are being evaluated for their ability to reproducibly attenuate each new variant of influenza A virus to a specific and desired level by the transfer of one or more attenuating genes. Each of these donor viruses has been able to attenuate influenza A viruses belonging to the H3N2 subtype by the transfer of one or more attenuating genes. To determine whether these two donor viruses could attenuate a wild-type virus that belonged to a different influenza A subtype, ts-1A2 and ca recombinants of a wild-type virus representative of the A/USSR/77 (H1N1) Russian influenza strain were prepared and evaluated in adult doubly seronegative volunteers at several doses. The recombinants derived from both donor viruses were attenuated for the doubly seronegative adults. Less than 5% of infected vaccinees developed a febrile or systemic reaction, whereas five of six recipients of wild-type virus developed such a response. The 50% human infectious dose (HID(50)) for each recombinant was approximately 10(5.0) 50% tissue culture infective doses. The virus shed by the ts-1A2 and ca vaccinees retained the ts or ca phenotype, or both. This occurred despite replication of the recombinant viruses for up to 9 days. No evidence for transmission of the ca or ts-1A2 recombinant virus to controls was observed. A serum hemagglutination inhibition response was detected in less than 50% of the infected vaccinees. However, with the more sensitive enzyme-linked immunosorbent assay, a serological response was detected in 100% of the ca vaccinees given 300 HID(50) and approximately 70% of ca or ts vaccinees who received 10 to 32 HID(50) of virus. These results indicate that the recombinants derived from both donor viruses were satisfactorily attenuated and were stable genetically after replication in doubly seronegative adults although they induced a lower serum hemagglutination inhibition response than that found previously for H3N2 ts and ca recombinants.

摘要

两种减毒甲型流感供体病毒,即A/Udorn/72 ts-1A2和A/Ann Arbor/6/60冷适应(ca)病毒,正在接受评估,以确定它们通过转移一个或多个减毒基因,将甲型流感病毒的每个新变种可重复地减毒到特定期望水平的能力。通过转移一个或多个减毒基因,这些供体病毒中的每一种都能够使属于H3N2亚型的甲型流感病毒减毒。为了确定这两种供体病毒是否能够使属于不同甲型流感亚型的野生型病毒减毒,制备了代表A/USSR/77(H1N1)俄罗斯流感毒株的野生型病毒的ts-1A2和ca重组体,并在成年双血清阴性志愿者中以几种剂量进行了评估。来自两种供体病毒的重组体对双血清阴性成年人是减毒的。不到5%的感染疫苗接种者出现发热或全身反应,而野生型病毒的六名接受者中有五人出现了这种反应。每种重组体的50%人感染剂量(HID(50))约为10(5.0) 50%组织培养感染剂量。ts-1A2和ca疫苗接种者排出的病毒保留了ts或ca表型,或两者皆有。尽管重组病毒复制长达9天,但仍出现这种情况。未观察到ca或ts-1A2重组病毒传播给对照的证据。在不到50%的感染疫苗接种者中检测到血清血凝抑制反应。然而,使用更敏感的酶联免疫吸附测定法,在给予300 HID(50)的ca疫苗接种者中100%检测到血清学反应,在接受10至32 HID(50)病毒的ca或ts疫苗接种者中约70%检测到血清学反应。这些结果表明,来自两种供体病毒的重组体减毒效果令人满意,并且在双血清阴性成年人中复制后基因稳定,尽管它们诱导的血清血凝抑制反应低于先前发现的H3N2 ts和ca重组体。

相似文献

引用本文的文献

本文引用的文献

5
Genetic approaches to attenuation of influenza A viruses for man.
Philos Trans R Soc Lond B Biol Sci. 1980 Feb 25;288(1029):401-15. doi: 10.1098/rstb.1980.0017.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验